ACG GI Pathophysiology Course 2021
Friday, October 22, 2021 │ All times are listed in the Pacific Time Zone | |
---|---|
7:00 am | Welcome and Introductions Darwin L. Conwell, MD, MS, FACG and Ikuo Hirano, MD, FACG |
7:05 am | Gastrointestinal and Hepatic Implications of COVID-19 Luis F. Lara, MD Identify the clinical implications of gastrointestinal and hepatic manifestations of SARS-CoV-2. |
7:35 am | Proton Pump Inhibitor Adverse Effects: Fact or Fiction? Paul Moayyedi, MB ChB, PhD, MPH, FACG Describe the scientific rationale and evidence for adverse effects of proton pump inhibitor therapy. |
8:05 am | Scientific Foundations of Novel Immunologic Approaches to IBD Miguel D. Regueiro, MD, FACG Apply concepts regarding the immunologic basis of novel biologic therapies to the management of IBD. |
8:35 am | Rationale for Targeting Eosinophils in Achalasia, Eosinophilic Gastrointestinal Disease, and Functional Gastrointestinal Disorders Nirmala P. Gonsalves, MD Appreciate the rationale for growing interest in novel therapies targeting eosinophils in the management of achalasia, eosinophilic gastrointestinal disease, and functional GI disorders. |
9:05 am | Q & A |
9:35 am | Break |
9:55 am | Pathophysiology Basis for Current and Future Management of Acute Pancreatitis George I. Papachristou, MD, PhD, FACG Identify the scientific basis for novel therapeutic approaches to pancreatitis. |
10:25 am | Application of Molecular and Genetic Testing to the Management of Colon Polyps and Cancer Elena M. Stoffel, MD, MPH Formulate a clinical approach to the use of molecular and genetic testing in the evaluation and management of colon polyps and cancer. |
10:55 am | Mechanistic Underpinnings for the Management of Refractory Constipation Darren M. Brenner, MD, FACG Apply concepts regarding the physiologic basis of constipation to inform therapeutic decisions for patients with refractory constipation. |
11:25 am | Celiac Disease: From Disease Understanding to Management Strategies Amy S. Oxentenko, MD, FACG Detail the mechanisms of celiac disease as well as diagnostic and management strategies for patients. |
11:55 am | Q & A and Course Wrap-Up |
12:30 pm | Course Adjourns |